Our Mission

The AGITG’s mission is the achievement of better health outcomes for patients with gastro-intestinal cancer through clinical trials research.

Scientific Objects

  1. to encourage members of the medical/scientific community through participation to assist in the conduct, evaluation, promotion and development of clinical trials in gastro-intestinal cancer;
  2. to promote the use of clinical trials in evaluating new treatments in gastro-intestinal malignancy and to improve the impact of new clinical trials on future clinical practice;
  3. to promote and conduct medical research for the prevention and mitigation of gastro-intestinal cancer;
  4. to promote improved clinical practice through professional meetings and educational symposia by working in collaboration with professional societies to pursue the objectives in (a), (b) and (c);
  5. to promote public education and awareness of gastro-intestinal cancer and its treatment; and
  6. to freely publish the results of research and clinical trials and to make available for general use, on the same terms to all interested bodies, licences for Australian and New Zealand patents issued in the course of research and clinical trials.